Cite
HARVARD Citation
Gehrke, T. et al. (2017). Zinc oxide nanoparticles antagonize the effect of Cetuximab on head and neck squamous cell carcinoma in vitro. Cancer biology & therapy. 18 (7), pp. 513-518. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gehrke, T. et al. (2017). Zinc oxide nanoparticles antagonize the effect of Cetuximab on head and neck squamous cell carcinoma in vitro. Cancer biology & therapy. 18 (7), pp. 513-518. [Online].